Herndon Capital Management’s Core Laboratories CLB Stock Holding History

Herndon Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-29,853	Closed	-$3.25M	–	189
2015 Q4	$3.25M	Sell	29,853 -25,098	-46%	-$2.87M	0.07%	46
2015 Q3	$5.48M	Sell	54,951 -1,606	-3%	-$175K	0.11%	49
2015 Q2	$6.45M	Sell	56,557 -4,563	-7%	-$553K	0.11%	46
2015 Q1	$6.38M	Sell	61,120 -326	-0.5%	-$34.7K	0.1%	45
2014 Q4	$7.39M	Buy	61,446 +24,925	+68%	+$3.27M	0.1%	45
2014 Q3	$5.34M	Buy	+36,521	New	+$5.64M	0.07%	53

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Herndon Capital Management's CLB Position: Q1 2016 in Review

Herndon Capital Management sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 29,853 shares — an estimated $3.25M sold.

Herndon Capital Management first reported a position in CLB in Q3 2014 and held it in 6 quarters. The position peaked at $7.39M in Q4 2014. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

Herndon Capital Management reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
Herndon Capital Management sold 29,853 Core Laboratories shares in Q1 2016, an estimated $3.25M.
Herndon Capital Management first reported a position in Core Laboratories in Q3 2014 and held it in 6 quarters.
Herndon Capital Management's Core Laboratories position peaked at $7.39M in Q4 2014.
365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on Herndon Capital Management's 13F filing for Q1 2016, filed 13 May 2016.